RAPT Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:RAPT Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
05 Jan 24	SellUS$20,456	Dirk Brockstedt	Individual		898	US$22.78

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RAPT?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	668,132	1.91%
VC/PE Firms	2,680,621	7.67%
General Public	4,112,918	11.8%
Institutions	27,496,582	78.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 76.67% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
15%	FMR LLC	5,235,521	US$4.3m	0%	no data
9.03%	The Vanguard Group, Inc.	3,156,005	US$2.6m	1.54%	no data
7.67%	The Column Group, LLC	2,680,621	US$2.2m	0%	4.27%
7.15%	BlackRock, Inc.	2,498,521	US$2.1m	2.41%	no data
4.93%	Kingdon Capital Management, L.L.C.	1,725,000	US$1.4m	0%	0.21%
3%	D. E. Shaw & Co., L.P.	1,048,186	US$865.2k	15.5%	no data
2.75%	Millennium Management LLC	959,965	US$792.4k	-6.26%	no data
2.41%	Acadian Asset Management LLC	842,157	US$695.1k	80.3%	no data
2.29%	Federated Hermes, Inc.	799,978	US$660.3k	0.49%	no data
2.02%	Two Sigma Advisers, LP	705,000	US$581.9k	0.95%	no data
1.95%	Geode Capital Management, LLC	683,179	US$563.9k	-0.22%	no data
1.94%	State Street Global Advisors, Inc.	679,508	US$560.9k	1.15%	no data
1.88%	Euclidean Capital LLC	657,899	US$543.0k	0%	0.06%
1.66%	Point72 Asset Management, L.P.	580,741	US$479.3k	-42.8%	no data
1.55%	GV Management Company, LLC	540,270	US$445.9k	0%	0.03%
1.49%	Two Sigma Investments, LP	520,422	US$429.6k	-15%	no data
1.46%	Pale Fire Capital SE	510,724	US$421.6k	3,080%	0.07%
1.44%	Redmile Group, LLC	504,532	US$416.4k	-5.99%	0.02%
1.42%	Cormorant Asset Management, LP	496,750	US$410.0k	0%	0.02%
1.41%	Brian Wong	492,618	US$406.6k	0%	no data
0.9%	Sio Capital Management, LLC	315,000	US$260.0k	0%	0.12%
0.86%	Bank of America Corporation, Asset Management Arm	299,531	US$247.2k	230%	no data
0.84%	Renaissance Technologies LLC	294,600	US$243.2k	44.5%	no data
0.84%	Octagon Capital Advisors LP	292,000	US$241.0k	0%	0.04%
0.82%	Deutsche Asset & Wealth Management	285,449	US$235.6k	-69.4%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 02:41
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

RAPT Therapeutics, Inc. is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Leon Wang	Barclays
Gao Yi Chen	Berenberg
Guyn Kim	BMO Capital Markets Equity Research